
Enveric Biosciences, Inc.
ENVBNasdaqCIK 890821HealthcareFiscal year ends Dec 31
Reports and events: 398 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2023-08-2107:55 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-029506 |
| 2023-08-1408:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-23-028048 |
| 2023-08-1117:11 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001493152-23-027881 |
| 2023-07-2408:15 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-025323 |
| 2023-07-1708:15 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-024675 |
| 2023-06-0918:49 ET | 10-K/A | Annual report, amendedPeriod 2022-12-31 | 0001493152-23-020625 |
| 2023-06-0708:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-020350 |
| 2023-06-0616:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-020298 |
| 2023-06-0508:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-020079 |
| 2023-05-3008:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-019398 |
| 2023-05-2408:00 ET | 8-K | 1.02 Termination of a material agreement; 5.02 Departure or appointment of officers or directors | 0001493152-23-018784 |
| 2023-05-2408:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-018782 |
| 2023-05-2208:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-018454 |
| 2023-05-1908:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-018221 |
| 2023-05-1808:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-018039 |
| 2023-05-1509:25 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001493152-23-016990 |
| 2023-04-1308:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-012081 |
| 2023-04-1010:11 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-011660 |
| 2023-04-0316:51 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-23-010655 |
| 2023-03-3117:25 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001493152-23-010431 |
| 2023-03-2307:45 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-008635 |
| 2023-03-2107:49 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-008322 |
| 2023-03-1408:08 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-007535 |
| 2023-02-2816:18 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-23-006267 |
| 2023-02-2307:33 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-005819 |
| 2022-11-1416:37 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001493152-22-032131 |
| 2022-10-2816:30 ET | 8-K | 5.07 Shareholder vote results | 0001493152-22-029856 |
| 2022-10-2408:58 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-22-029389 |
| 2022-10-0617:00 ET | 8-K/A | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001493152-22-027827 |
| 2022-09-2317:02 ET | DEF 14A | Proxy statementPeriod 2022-09-23 | 0001493152-22-026706 |
| 2022-09-2317:00 ET | 8-K | 4.01 Change of auditor | 0001493152-22-026704 |
| 2022-09-1409:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-22-025818 |
| 2022-09-1314:44 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001493152-22-025724 |
| 2022-09-0115:57 ET | 8-K | 5.08 Item not in the standard list | 0001493152-22-024837 |
| 2022-08-1216:23 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001493152-22-022369 |
| 2022-08-0216:30 ET | 8-K | 3.01 Delisting notice | 0001493152-22-021011 |
| 2022-07-2617:15 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-22-020362 |
| 2022-07-1908:25 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-22-019757 |
| 2022-07-1816:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001493152-22-019579 |
| 2022-07-1417:09 ET | 8-K | 3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-22-019341 |
| 2022-07-1310:34 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-22-019134 |
| 2022-06-1509:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001493152-22-016803 |
| 2022-05-3116:15 ET | DEF 14A | Proxy statementPeriod 2022-05-31 | 0001493152-22-015464 |
| 2022-05-2416:48 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-22-014962 |
| 2022-05-1816:24 ET | 8-K/A | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-22-014325 |
| 2022-05-1316:16 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001493152-22-013332 |
| 2022-05-1113:46 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-22-012822 |
| 2022-05-0417:27 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-22-012133 |
| 2022-05-0417:12 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001493152-22-012127 |
| 2022-04-0113:34 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-22-008737 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 20:02 ET. Listed shows no prices and gives no investment advice.